Results 151 to 160 of about 15,943 (285)

A core outcome set and reporting checklist for research on critically ill obstetric patients: An international consensus study

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
An international, multi‐method consensus process identified 10 core outcomes, 7 reporting items, and 4 noncore outcomes to standardize outcome reporting, reduce heterogeneity, and improve comparability and patient‐centeredness of research on critically ill obstetric patients.
Tiffany Yeretsian, Julien Viau‐Lapointe, Rizwana Ashraf, Rohan D'Souza, Stephen E. Lapinsky   +4 more
wiley   +1 more source

Correction: The MYH7 c.2770G > A (p.Glu924Lys) mutation exhibits phenotypic heterogeneity in hypertrophic cardiomyopathy (HCM) and restrictive cardiomyopathy (RCM): a case report. [PDF]

BMC Cardiovasc Disord
Han Y, Wang H, Zhang H, Wang M, Gan L, Meng F.   +5 more
europepmc   +1 more source

Restrictive cardiomyopathy: definition and diagnosis. [PDF]

Eur Heart J, 2022
Rapezzi C, Aimo A, Barison A, Emdin M, Porcari A, Linhart A, Keren A, Merlo M, Sinagra G.   +8 more
europepmc   +1 more source

A Clinical Case of Familial Desmin Cardiomyopathy with a Restrictive Phenotype

Л.Л. Саркисян, А. М. Намитоков   +1 more
openalex   +1 more source

Three Ventricular Assist Devices (True TriVAD) as Bridge to Durable Biventricular Support (BiVAD) in LVAD Patient With Severe Aortic Regurgitation

Artificial Organs, EarlyView.
An LVAD patient with severe aortic regurgitation (AR) developed right heart failure and multi‐organ dysfunction (MOD). tRVAD support caused LV overload and pulmonary edema. Impella 5.5 implantation successfully unloaded the LV and stabilized the patient, enabling durable RVAD implantation with surgical aortic valve replacement.
Nikolaos Cholevas, Felix Schoenrath, Nicolas Merke, Denis Fries, Marcus Mueller, Johanna Mulzer, Evgenij Potapov   +6 more
wiley   +1 more source

<i>TPM1</i>-p.E181K mutation suppresses CaMKII/HDAC4 signaling pathway leading to pediatric restrictive cardiomyopathy. [PDF]

Front Genet
Fu J, Zhang J, Zhang Y, Sun D, Xia K, Wang R, Feng X, Zhai A, Huang Y, Li X, Yu W, Zhang Y.   +11 more
europepmc   +1 more source

Hemocompatibility and Long‐Term Outcomes in HeartWare Versus HeartMate II Versus HeartMate 3: Multicenter Real‐World Cohort

Artificial Organs, EarlyView.
Multicenter real‐world cohort (n = 327) comparing LVADs: HeartMate 3 (HM3), HeartMate II (HMII), and HeartWare (HVAD). HM3 showed superior long‐term survival versus legacy devices, driven by fewer hemocompatibility‐related adverse events, especially pump thrombosis and ischemic stroke, while major bleeding was similar across devices.
Hamza H. H. Ben Nasir, Ahmed F. A. Mohammed, Omar Allham, Alish Kolashov, Yusuf Shieba, Lachmandath Tewarie, Bernd Panholzer, Ajay Moza, Assad Haneya, Rashad Zayat   +9 more
wiley   +1 more source

Editorial: Cardiovascular genetics—focus on paediatric cardiomyopathy

Frontiers in Pediatrics, 2023
Emanuele Monda, Juan Pablo Kaski, Giuseppe Limongelli, Giuseppe Limongelli   +3 more
doaj   +1 more source

Restrictive cardiomyopathy due to new mutation in the ACTN2 gene: a case report. [PDF]

Eur Heart J Case Rep
Lan B, Liu Z, Bai J, Tang J, Zhang J.
europepmc   +1 more source

Bleeding Disorders in Children With Genetic Diseases: A Narrative Review

Acta Paediatrica, EarlyView.
ABSTRACT Aim The lack of data on bleeding risk assessment in children with genetic diseases is concerning given their increased care needs and risk of haemorrhagic complications compared to the general population. Identification of haemostatic disorders is crucial for implementing preventive measures and mitigating bleeding risk.
Raphaelle Cagol, Mariam Sbeity Barakat, Marjolaine Willems, Tasnime Akbaraly, Biron‐Andreani Christine, Isabelle Diaz, Alexandre Theron   +6 more
wiley   +1 more source